We also analyzed the mRNA expression of FABP4 and SREBP1, which is linked to liver lipid storage, liver steatosis, liver lipogenesis, and NAFLD pathogenesis [39,48]. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.